Malaria-Cutaneous Leishmaniasis Co-infection: Influence on Disease Outcomes and Immune Response by Raquel A. Pinna et al.
fmicb-07-00982 June 24, 2016 Time: 16:57 # 1
ORIGINAL RESEARCH
published: 27 June 2016
doi: 10.3389/fmicb.2016.00982
Edited by:
Emilio Luis Malchiodi,
University of Buenos Aires, Argentina
Reviewed by:
Hira Nakhasi,
United States Food and Drug
Administration, USA
Rodolfo Cordeiro Giunchetti,
Universidade Federal de Minas
Gerais, Brazil
*Correspondence:
Paula M. De Luca
pmdeluca@ioc.fiocruz.br;
Dalma M. Banic
banic@ioc.fiocruz.br
Specialty section:
This article was submitted to
Microbial Immunology,
a section of the journal
Frontiers in Microbiology
Received: 25 March 2016
Accepted: 07 June 2016
Published: 27 June 2016
Citation:
Pinna RA, Silva-dos-Santos D,
Perce-da-Silva DS,
Oliveira-Ferreira J, Villa-Verde DMS,
De Luca PM and Banic DM (2016)
Malaria-Cutaneous Leishmaniasis
Co-infection: Influence on Disease
Outcomes and Immune Response.
Front. Microbiol. 7:982.
doi: 10.3389/fmicb.2016.00982
Malaria-Cutaneous Leishmaniasis
Co-infection: Influence on Disease
Outcomes and Immune Response
Raquel A. Pinna1, Danielle Silva-dos-Santos2, Daiana S. Perce-da-Silva1,
Joseli Oliveira-Ferreira3, Dea M. S. Villa-Verde2, Paula M. De Luca3* and
Dalma M. Banic1*
1 Laboratory of Simulids, Onchocerciasis and Sympatric Diseases: Mansonelliasis and Malaria, Oswaldo Cruz Institute,
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2 Laboratory of Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz
Foundation, Rio de Janeiro, Brazil, 3 Laboratory of Immunoparasitology Research, Oswaldo Cruz Institute, Oswaldo Cruz
Foundation, Rio de Janeiro, Brazil
Malaria and Cutaneous Leishmaniasis (CL) are co-endemic throughout large regions
in tropical countries and co-infection may impact the evolution of host-parasite
interactions. In the present study, we evaluate Malaria/Leishmaniasis disease outcome,
Th1/Th2 cytokine levels and the CD4 and CD8 T-cell profiles in a co-infection murine
model (BALB/c) of Plasmodium yoelii 17XNL (Py) and Leishmania amazonensis (La)
or L. braziliensis (Lb). Malaria parasitaemia was assessed through blood strains stained
with Giemsa. Leishmania lesions were monitored with a digital caliper and parasite loads
determined by limiting-dilution assay. Serum levels of IFN-γ, TNF, IL-2, IL-4, IL-6, IL-10,
and IL-17 were determined using multiplexed bead assay and expression of CD3, CD4,
and CD8 T-cells markers were determined by Flow Cytometry in the thymus, spleens
and lymph nodes. Parasitaemia in Lb+Py co-infected group was lower than in Py single-
infected group, suggesting a protective effect of Lb co-infection in Malaria progression.
In contrast, La+Py co-infection increased parasitaemia, patent infection and induced
mortality in non-lethal Malaria infection. Regarding Leishmaniasis, Lb+Py co-infected
group presented smaller lesions and less ulceration than Lb single-infected animals. In
contrast, La+Py co-infected group presented only a transitory delay on the development
of lesions when compared to La single-infected mice. Decreased levels of IFN-γ, TNF,
IL-6, and IL-10 were observed in the serum of co-infected groups, demonstrating a
modulation of Malaria immune response by Leishmania co-infections. We observed an
intense thymic atrophy in Py single-infected and co-infected groups, which recovered
earlier in co-infected animals. The CD4 and CD8 T cell profiles in thymus, spleens and
lymph nodes did not differ between Py single and co-infected groups, except for a
decrease in CD4+CD8+ T cells which also increased faster in co-infected mice. Our
results suggest that Py and Leishmania co-infection may change disease outcome.
Interestingly Malaria outcome can be altered according to the Leishmania specie
involved. Alternatively Malaria infection reduced the severity or delayed the onset of
leishmanial lesions. These alterations in Malaria and CL development seem to be closely
related with changes in the immune response as demonstrated by alteration in serum
cytokine levels and thymus/spleens T cell phenotypes dynamics during infection.
Keywords: co-infection, Malaria, Leishmaniasis, immunology, cytokine, Plasmodium yoelii, Leishmania
braziliensis, Leishmania amazonensis
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INTRODUCTION
Malaria and Cutaneous Leishmaniasis (CL) are two of the
world’s most important vector-borne parasitic diseases (World
Health Organization, 2010, 2015; Alvar et al., 2012). Malaria,
an infectious disease caused by Plasmodium genus parasites,
is an important cause of global mortality and morbidity. Half
of the world population is at risk of contracting Malaria,
with approximately 214 million cases and 438 000 deaths in
2015, amongst the 3.2 billion people living at risk of infection
(World Health Organization, 2015). Humans can be infected
by five Plasmodium species: P. falciparum, P. vivax, P. ovale,
P. malariae, and P. knowlesi. Although P. falciparum accounts
for the great majority of morbidity and mortality, P. vivax
has a wider geographic distribution and causes considerable
symptomatic disease (Battle et al., 2014). Malaria infection has
a variable clinical phenotype, ranging from a mild febrile illness
to severe disease and death, but infection can also occur in
the absence of clinical symptoms. These variations in disease
pattern are attributable to many factors, including the genetic
background of the host and pathogen, the complex relationship
between the parasite and host immune response, the dynamics
of parasite transmission and/or the biological interactions of
the parasites within the host (Good and Doolan, 2010; van
den Bogaart et al., 2012). Leishmaniasis is a complex disease
caused by different species of intracellular protozoan parasites
from the genus Leishmania, which also induces significant
morbidity and mortality throughout the world. According to
the World Health Organization (2016) 350 million people in
98 countries are at risk of infection. There are an estimated
annual 1.3 million new cases worldwide, of which 300,000 cases
are of Visceral Leishmaniasis (VL) and another 1 million of
CL. Seventy (70) to 75% of the CL cases occur in Afghanistan,
Algeria, Brazil, Colombia, Costa Rica, Ethiopia, Iran, Peru,
Sudan, and Syria (World Health Organization, 2016). CL is
caused by L. major, L. tropica, and L. aethiopica in the Old
World, whereas in the New World it is most frequently caused
by L. mexicana, L. amazonensis, L. braziliensis, L. panamensis,
and L. guyanensis (World Health Organization, 2010; Hartley
et al., 2014). Symptoms range from the more prevalent single self-
healing cutaneous lesions to uncontrolled parasite replication,
producing non-healing cutaneous, mucosal or even visceral
disease as well as chronic metastatic dissemination throughout
the skin. This spectrum of manifestations is multifactorial and
depends on complex interactions among parasite, host, and
environmental factors, including the Leishmania specie, genetic
background and immunological status of the host (Hartley et al.,
2014).
The overlapping geographic distribution of Malaria and
Leishmaniasis, especially in the tropical and subtropical countries
demonstrate clearly that the potential for interaction among
these parasites may occur and play a role in determining disease
outcome (Hotez et al., 2006; van den Bogaart et al., 2012,
2014). Despite this natural coexistence, data from concomitant
infections are so far not available in the literature (Ab Rahman
and Abdullah, 2011; van den Bogaart et al., 2012, 2014).
Therefore, the impact of the dual infections on the human
population health remains unassessed particularly in what
concerns CL.
In the eighties, two studies in the murine model evaluated
the effect of non-lethal P. yoelii and L. amazonensis concomitant
infections in the course of each disease (Coleman et al., 1988a,b).
These studies demonstrated that severity and susceptibility to
both diseases were enhanced during co-infection. Since these
parasites do not compete for the same host cells, neither
anatomical sites nor resources, the interaction among them is
most likely indirect and related mostly to the host’s immune
responses induced by each pathogen. However, in both studies
(Coleman et al., 1988a,b) the immunological mechanisms
involved were not investigated. Alternatively, several studies have
shown that outcome of Malaria and CL is determined, in part,
by the balance of pro- and anti-inflammatory immune responses
(Louis et al., 1998; Li et al., 2001; Silveira et al., 2009; Taylor-
Robinson, 2010; Medina et al., 2011; Freitas do Rosario and
Langhorne, 2012; Kedzierski and Evans, 2014).
The immune response against the blood stages of Malaria
parasites operate in concert and sequentially to control and
clear the parasitaemia by an early and strong pro inflammatory,
type 1 response (Th1), limiting parasite growth, followed by
a shift to anti-inflammatory, type 2 immune (Th2) response.
The balance between cytokines produced by pro inflammatory
and anti-inflammatory responses during different phases of the
blood stage infection determines the outcome of the disease
(Li et al., 2001). In contrast to the strong type 1 immune
response at the beginning of the Malaria infection, CL caused
by L. amazonensis generally results in type 2 cellular immune
response polarization (Silveira et al., 2009; Gollob et al., 2014).
On the other hand, in CL caused by L. braziliensis, there is
evidence that increased production of inflammatory cytokines
(IFN-γ and TNF-α) and absence of IL-10 is associated with
tissue destruction and the development of mucosal lesions (Dutra
et al., 2011; Gollob et al., 2014; Oliveira et al., 2014). In this
context, the current study was designed to evaluate the outcome
of Malaria-CL infections, the CD4 and CD8 T-cell profiles as well
as the Th1/Th2 cytokine levels in a co-infection murine model
(BALB/c) of P. yoelii 17XNL (non-lethal) and L. amazonensis or
L. braziliensis. Furthermore, as far as we know, this is the first
report utilizing L. braziliensis and P. yoelii 17XNL non-lethal
strain as a co-infection model.
MATERIALS AND METHODS
Animals, Parasites, and Infections
Female BALB/c mice (5–6 weeks old) were obtained from
the Center for Laboratory Animal Breeding of the Oswaldo
Cruz Foundation (FIOCRUZ) (Rio de Janeiro, RJ, Brazil).
Mice were maintained under specific pathogen-free conditions
in Experimental Animal Center of Leônidas Deane building
(FIOCRUZ). This research protocol was approved by the Ethical
Committee for Animal Use of FIOCRUZ/MS (license LW-17/11).
P. yoelii 17XNL (non-lethal strain) was provided by Dr Fábio
T.M. Costa at Departamento de Genética, Evolução e Bioagentes,
Instituto de Biologia, UNICAMP, Campinas, SP, Brazil. Parasite
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stabilates were stored at −196◦C. To obtain the experimental
inoculum of P. yoelii 17XNL, parasitized red blood cells (pRBCs)
were defrosted and passed through three homologous donor
mice.
Promastigotes of L. braziliensis (MCAN/BR/98/R69) and
L. amazonensis (IFLA/BR/67/PH8), provided by Laboratório de
Pesquisa em Leishmaniose, Instituto Oswaldo Cruz, FIOCRUZ,
RJ, Brazil, were cultured in Schneider’s medium supplemented
with antibiotics (200 IU penicillin and 200 µg streptomycin/ml)
and 10% inactivated fetal calf serum (all from Sigma–Aldrich, St
Louis, MO, USA). For L braziliensis 2% of sterile human urine
was also added to the cultures (Howard et al., 1991).
Eight to nine-week-old mice (∼22g each) were divided
randomly into six groups, Figure 1. Group C: comprised
uninfected mice; Group Py: mice were injected intraperitoneally
(i.p.) with 106 P. yoelii 17XNL pRBCs (0.2 mL); Groups Lb and
La: mice were inoculated intradermally in both ears with either
105 or 104 stationary phase promastigotes of L. braziliensis or
L. amazonensis, respectively, as previously described (Belkaid
et al., 2000); Groups Lb+Py and La+Py: mice were co-
infected with both P. yoelii 17XNL and either L. braziliensis or
L. amazonensis. Each group had 25 to 35 mice and experiments
were repeated at least three times. First, mice were infected with
Leishmania sp. and 3 days later with P. yoelii 17XNL, as shown in
Figure 1. At 5, 10, 17, and 25 days post-P. yoelii 17XNL infection,
six animals from each group were bled, for serum cytokine
assay, and euthanized, for thymus, spleen, ears and lymph nodes
removal. Mortality of mice was monitored daily, post-P. yoelii
17XNL infection.
Determination of Parasite Load,
Leishmania Lesion Size, and Ulceration
Malaria parasitaemia was monitored every 2 days starting at
day 3 post-infection. Blood smears were prepared from tail
vein, methanol-fixed, stained with Giemsa and microscopically
FIGURE 1 | Experimental design. Mice were infected with Leishmania
braziliensis. (black circles) or L. amazonensis (gray circles) 3 days before
Plasmodium yoelii infection (white circles). On days 5, 10, 17, and 25 post
P. yoelii infection (vertical arrows), six mice from Py, Lb, La, Lb+Py, and La+Py
groups and four mice from control (C) group were euthanized to evaluate
parasite loads in the ears and draining lymph nodes (Lb/La and
Lb+Py/La+Py groups), cytokine serum levels (all groups), thymus relative
weight (all groups), absolute numbers of thymocytes (all groups) and
phenotyping of T cells in the thymus, spleen and lymph nodes (all groups).
examined to determine parasitaemia in 1,000 erythrocytes. The
percentage of infected erythrocytes was calculated as follows:
Parasitaemia (%)= (number of infected erythrocytes x 100)/total
number of erythrocytes counted (1,000).
The diameter of dermal Leishmania sp. lesions were measured
weekly with a digital calipter. We also monitored the time elapsed
until ulcer formation in nodules. Parasite numbers in the ears and
draining lymph nodes were determined as previously described
(Belkaid et al., 2000) and scored as the highest dilution containing
viable parasites after incubation for 6 days at 26◦C.
Cytokines Quantitation in the Serum
The serum levels of cytokines (interferon – IFN-γ, tumor necrose
factor – TNF, interleukin (IL)-2, IL-4, IL-6, IL-10, and IL-17)
were determined using the BD Cytometric Bead Array Kit Mouse
Th1/Th2/Th17 Cytokines (BD Biosciences, San Jose, CA, USA)
according to the manufacturer’s instructions. Briefly, 25 µL of
mouse serum was incubated for 2 h at room temperature with
25 µL of cytokine capture bead and 25 µL of phycoerythrin
(PE) detection reagent. Then, samples were washed with 1 mL
of buffer by centrifugation (200 × g, 5 min). The supernatants
were carefully aspirated and discarded from each assay tube.
Finally, beads were resuspended in 300 µL of buffer for analysis
on a FACSCalibur flow cytometer (Becton Dickinson, San Jose,
CA, USA). The serum cytokine concentrations (pg/mL) were
determined using a standard curve from recombinant cytokines
provided by the kit.
Determination of Thymus Relative
Weight
For determination of thymus relative weight, body and thymus
of each mouse were weighted. Thymic index (TI) was calculated
according to the following formula: TI = thymus weight (mg) /
body weight (g).
T Cell Phenotyping by Flow Cytometry
Thymus, spleens, mesenteric nodes, subcutaneous nodes
(cervical, axillary, brachial, and inguinal) and submandibular
nodes (draining ears lesions) were dissected and mechanically
disaggregated. Single-cell suspensions from control, infected and
co-infected mice were obtained in RPMI-1640 supplemented
with 10% fetal calf serum (Gibco-Invitrogen, USA). Cell numbers
and viability were determined by Trypan blue exclusion using
Neubauer chamber.
For T lymphocytes phenotypic characterization, 106 cells
were stained with FITC labeled anti-mouse CD4, APC labeled
anti- mouse CD8 and PE labeled anti-mouse CD3 monoclonal
antibodies. After incubation for 30 min, followed by 2 washes
with staining buffer (PBS, 0,1% BSA, 0,01% sodium azide, all
from Sigma–Aldrich), cells were fixed with 1% paraformaldehyde
solution (Sigma–Aldrich), washed and resuspended in staining
buffer until acquisition. A minimum of 30,000 events per sample
were acquired inside the lymphocytes gate, based on size and
granularity properties using a FACSCantoIITM flow cytometer
(BD Bioscience, USA) and analyzed using FlowJo 7.5.5 software
(Tree Star Inc. Ashland, OR, USA).
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Statistical Analysis
Sample size was determined a priori using the software
G*Power version 3.1.9.2, based on the Mann–Whitney test,
a significance level of 0.05, and a minimum power of 80%.
Results were evaluated by a non-parametric test, the Mann–
Whitney test, using GraphPad Prism software version 5.0
(GraphPad Software, La Jolla, CA, USA). Data are expressed
as means ± SEM and considered to be statistically significant
when p < 0.05. Survival curves were analyzed by Mantel Cox
and Gehan–Breslow–Wilcoxon tests and Leishmania lesions
ulcerations were analyzed by Chi-square test using the same
software.
RESULTS
L. braziliensis and L. amazonensis
co-Infection exerts opposite effects on P.
yoelii 17XNL Infection
Blood stage P. yoelii 17XNL parasites induced Malaria infection
in all BALB/c mice from single-infected (Py) and L. braziliensis
or L. amazonensis co-infected groups (Lb+Py and La+Py).
Parasitaemia peak occurred between 10 and 17 days after
infection and no parasite was detected after 23 days post-
infection in blood smears of Py single-infected mice. The overall
mean parasitaemia observed in Lb+Py co-infected group was
lower than that observed in P. yoelii single-infected group
(Py). Statistically significant differences observed in some days
are suggestive for a protective effect of L. braziliensis co-
infection in Malaria progression (Figure 2A). In contrast,
co-infection with L. amazonensis appears to have a negative
influence in acute Malaria (Figure 2C), and mortality in
La+Py co-infected group enhanced in comparison to Py single
infected group (Figure 2D). La+Py group exhibited higher
parasitaemia on day 5 and a longer course of P. yoelii
Malaria patency with mice remaining parasitemic 8 days
longer than mice in Py single-infected group (Figure 2C). The
higher rate of parasitemia in La+Py coinfeted mice seems
to be associated with decreased survival. Four weeks after
P. yoelii 17XNL infection, 30% of the co-infected La+Py
mice were dead, compared to 100% of survival in the
group infected only with P. yoelii 17XNL. Py single-infected
groups showed no mortality during the whole experiment
(Figures 2B,D).
Co-Infection is Able to Reduce Severity
of L. braziliensis Lesions
BALB/c mice were intradermally infected with 105 stationary
phase promastigotes of L. braziliensis. Lb+Py co-infected group
showed an overall tendency to present smaller lesion sizes than
Lb single infected group (Figure 3A). In both groups, lesions
reached maximum size 5 weeks post-infection and started to
heal afterward. To evaluate disease severity we followed the
onset of open ulcers in Leishmania-infected and co-infected
groups (Figure 3B). Ulcers started to appear 21 days post-
infection in Lb group and after 28 days in Lb+Py. At week
11 after infection (77 days) Lb single-infected group presented
a higher number of ulcerated nodules (83.3%) than Lb+Py
(40.9%). At week 17 and 18 post infection, there was a complete
resolution of lesions in Lb+Py and Lb groups, respectively
(data not shown). Limiting-dilution assays performed in the
ears and in draining lymph nodes showed an earlier detection
of parasites in the ears of Lb single-infected animals than in
co-infected group (14 and 21 days post-infection, respectively)
with no difference in parasite loads between groups. On
the other hand, in the draining lymph nodes parasites were
detected 28 days after infection in both groups, and parasite
loads were lower in Lb+Py co-infected group (p = 0.006,
Figures 3C,D).
Co-Infection Reduce Severity of L.
amazonensis Lesions Only during Acute
Phase Malaria
Infection of BALB/c mice with 104 stationary phase
promastigotes of L. amazonensis induced chronic lesions
that did not heal over time in La and La+Py groups (Figure 4A).
During murine Malaria (from day 0 to day 25) lesions in
La+Py co-infected group were significantly smaller than
in La single infected group. Although lesions of La group
presented greater sizes than La+Py until 28 days of infection,
after that time and until the end of the experiment both
groups present similar lesion sizes. Ulcerated nodules were
detected first in La group (21 days post-infection) while
in La+Py group visual detection occurred 1 week later
(28 days post-infection) (Figure 4B). However, after 63 days
of infection all animals from both groups presented ulcerated
nodules. Limiting dilution analysis performed at the site
of infection and in draining lymph nodes showed higher
parasite loads in La+Py group than La single-infected group
(Figures 4C,D).
Co-Infection Modulate Serum Cytokine
Levels Induced by P. yoelii 17XNL
Cytokine levels were measured in serum samples obtained from 4
to 6 animals of each experimental group. As expected, increased
levels of the proinflammatory cytokine IFN-γ, were observed
in all groups infected with P. yoelii 17XNL (Py, Lb+Py, and
La+Py) in the first week of infection (day 5). The levels of
TNF, IL-6 and IL-10 also increased in the serum of the same
three groups during blood stage Malaria. Cytokine levels in co-
infected groups (Lb+Py and La+Py) were clearly lower than
those observed in Malaria single infected group (Py) suggesting
a modulatory effect of co-infection (Figure 5). We were not able
to detect any of the analyzed cytokines in serum samples from
control and Lb or La single infected animals, except for IL-10
in La infected group, only at day 25th post infection. Although
we could observe a tendency for an increased production of
TNF, IL-6 and IL-10 in the first 10 days of Malaria infection
for Lb+Py co-infected group when compared to La+Py co-
infected animals, statistic difference was observed only for IL-
6 at day 10 post Py infection (P = 0.045). We were not
able to detect the cytokines IL-2, IL-4, and IL-17 in serum
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FIGURE 2 | Parasitaemia and survival rate of BALB/c mice infected with blood-stage P. yoelli 17XNL non-lethal strain and co-infected with
Leishmania sp. and P. yoelii 17XNL. (A,C) Malaria parasitaemia in P. yoelii single-infected mice (Py) and in mice co-infected with L. braziliensis/P. yoelii (Lb+Py) (A)
or with L. amazonensis/P. yoelii (La+Py) (C). (B,D) Comparison of the survival rate in Py single-infected and Lb+Py co-infected (B) or La+Py co-infected mice (D).
Parasitaemia results are expressed by the mean ± SEM of at least 10 mice per group. The Mann–Whitney test was used to compare Py single-infected and
co-infected groups. Survival rates were compared by Mantel-Cox test. ∗p < 0.05 and ∗∗p < 0.01, respectively. Arrows indicate the time of Leishmania (a) and
P. yoelii (b) infection.
samples from all experimental groups, at any time of the
study.
Recovery of Thymic Atrophy Occurs
Earlier in Co-Infected Animals
In the course of Malaria infection, we observed a significant
reduction of the thymus relative weight in comparison to the
uninfected control group. Thymic atrophy was first observed
10 days post P. yoelii infection (dpi) and persisted until
day 25th of infection in Py single-infected group. In co-
infected groups (Lb+Py and La+Py) thymus relative weight
came back to normal values at 25 day post-infection and
no significant difference could be observed in comparison to
the control group. During the entire experiment, Leishmania
single-infected groups showed no differences in thymus relative
weight when compared do the uninfected control group
(Figure 6).
Flow cytometry analysis showed that the thymus of Py and
co-infected groups underwent a decrease in CD4+CD8+ double-
positive (DP) T cell subset and an increase in CD4+ single-
positive (SP), CD8+SP and CD4−CD8− double-negative (DN)
T cell populations (Figure 7). A significant increase in CD4+SP
thymocytes occurred at 17 dpi and persisted up to 25 dpi in Py
single-infected animals. In Lb+Py group, CD4+SP thymocytes
increased 10 days post infection, and returned to control values
by day 25th post infection. In La+Py this transitory increase was
observed latter at 17 dpi. The dynamics of CD8+SP thymocytes
in single infected and co-infected groups exhibited the same
profile of CD4+SP. When we evaluate this results together, it
is possible to notice that in Lb+Py co-infection, the increase in
CD4+SP and CD8+SP occurred sooner than in La+Py group (10
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FIGURE 3 | Evaluation of L. braziliensis infection. (A) Lesion development, (B) onset of open ulcers, and (C) parasite quantitation in infected ears and (D)
draining lymph nodes of BALB/c mice after intradermal infection in the ears with L. braziliensis promastigotes (Lb) or co-infected with L. braziliensis and P. yoelii
(Lb+Py). Parasite loads were individually determined by a limited dilution assay. Results are expressed by the mean ± SEM of twelve ears and lymph nodes. The
Mann–Whitney test was used to compare lesion size (A) and parasite loads in ears (C) and draining lymph nodes (D). Chi-square test was used to evaluate
ulcerations (B). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, respectively. Arrows indicate the time of L. braziliensis (a) and P. yoelii (b) infection.
and 17 dpi, respectively). Double-negative thymocytes increased
in Py single-infection at 17 and 25 dpi. The same increase
occurred in co-infected groups only at day 17 post infection.
In parallel, CD4+CD8+ DP cells significantly decreased in the
thymus of Py single infected animals at 17 dpi and remained
lower at 25 dpi. This decrease was observed earlier is Lb+Py
group (10 dpi) but, at day 25th post infection, DP cells increased
in this group and were higher than in control and single infected
groups. Interestingly, in La+Py co-infected group, the increase
in DP thymocytes occurred earlier (10 dpi) and was followed
by a rapid decrease at day 17th post infection, coming back
to control values 25 dpi. Overall, thymus recovery seems to
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FIGURE 4 | Evaluation of L. amazonensis infection. (A) Lesion development, (B) onset of open ulcers, and (C) parasite quantitation in infected ears and (D)
draining lymph nodes of BALB/c mice after intradermal infection in the ears with L. amazonensis promastigotes (La) or co-infected with L. amazonensis and P. yoelii
(La+Py). Parasite loads were individually determined by a limited dilution assay. Results are expressed by the mean ± SEM of twelve ears and lymph nodes. The
Mann–Whitney test was used to compare parasite loads in ears and draining lymph nodes. ∗p < 0.05 and ∗∗p < 0.01, respectively. Arrows indicate the time of
L. braziliensis (a) and P. yoelii (b) infection.
occur faster in Malaria/Leishmania co-infection than in Py single
infection.
Leishmania Co-Infection Delay the
Enhancement of Double Negative Cells
Induced by P. yoelii 17XNL Infection in
the Spleen
We also evaluated the T cell phenotypes present in the spleens,
mesenteric, subcutaneous and submandibular nodes (the last
ones as the draining nodes from ears lesions) in single infected
and co-infected animals. No alterations were observed in the
T cell phenotypes present in subcutaneous and submandibular
nodes among the studied groups, while in mesenteric nodes and
spleens we were able to observe similar patterns of alterations
that were more evident in the spleens (Figure 8). After a
transitory increase at 10 dpi in Py single infected and in co-
infected groups, CD4+ T cells dropped in Py single infected
group at 17 dpi and remained bellow controls at 25 dpi. In
Lb+Py co-infected group a significant decrease was observed
only at 25 dpi. Py single infected animals also presented a
significant drop in the percentages of CD8+T cells. In co-infected
groups, the percentages of CD8+T cells were bellow controls
at 10, 17, and 25 dpi. Low percentages of DP splenocytes were
observed in Py single infected and co-infected groups, which were
different form controls only when animals started to recover from
malarial infection (17 and 25 dpi). On the other hand, P. yoelii
infection increased the percentage of DN splenocytes during the
entire experiment, and Leishmania co-infection was able to delay
this enhancement. The percentages of CD4, CD8, DP, and DN
splenocytes in Leishmania single infected groups (both Lb and
La) remained similar to uninfected controls at all time points.
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FIGURE 5 | Kinetics of cytokine levels in the serum of mice infected with P. yoelii (Py), L. braziliensis (Lb), L. amazonensis (La) or co-infection with
Leishmania sp. and P. yoelii. Serum levels of IFN, TNF, IL-6, and IL-10 were determined by Cytokine Bead Array. Cytokine levels obtained in the serum of
non-infected controls (open bars) were compared to those obtained in Py single-infected mice (black bars) and in animals co-infected (checkered bars) or single
infected (gray bars) with L. braziliensis (A) or L. amazonensis promastigotes (B). Results are expressed by the mean ± SEM of 4–6 mice per group. The
Mann–Whitney test was used to compare serum cytokine levels between groups. ∗p < 0.05 and ∗∗p < 0.01, respectively.
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FIGURE 6 | Alterations in the thymus relative weight after infection with P. yoelii (Py), L. braziliensis (Lb), L. amazonensis (La), or co-infection with
Leishmania sp. and P. yoelii. Thymus relative weight in uninfected controls (open bars) were compared to those obtained in Py single-infected mice (black bars)
and in animals co-infected (checkered bars) or single infected (gray bars) with L. braziliensis (A) or L. amazonensis promastigotes (B). Results are expressed by the
mean ± SEM of 4–6 mice per group. The Mann–Whitney test was used to compare thymus relative weight between groups. (∗) statistically different from control, (#)
statistically different from Leishmania single infection and (§) statistically different from Leishmania/P. yoelii co-infected group.
DISCUSSION
Malaria and CL are neglected diseases spread over many
tropical and subtropical regions of the World showing extensive
overlapping geographic distribution. In addition, the increase
in travel, migration and war refugees from endemic regions
are factors that also contribute to the risk of simultaneous
infections by Plasmodium spp. and Leishmania spp. parasites.
Some cases of human Malaria and VL co-infection were
described in the past and recently in different parts of the world
(Yoeli, 1948; Ab Rahman and Abdullah, 2011; van den Bogaart
et al., 2012, 2014; Bin Mohanna, 2015), demonstrating that co-
infection may occur more frequently than we would expect. An
increasing amount of evidence shows that co-infections may
affect the natural outcome and progression of diseases due to
the modulation of immune response (La Flamme et al., 2002;
Kolbaum et al., 2012; Qi et al., 2013; van den Bogaart et al.,
2014). In the present study, we established a co-infection model of
American CL and a non-lethal murine Malaria and demonstrated
that co-infection is able to affect the pathogenesis and outcome of
both diseases.
Pilot studies were carried out in our Laboratory in which mice
were co-infected at different times and orders. It was observed
that the outcome of malaria or Leishmania infections were the
same in any time and order of infections tested. For operational
reasons we selected day 3 for Py infection. In addition, our
results regarding the outcome of both diseases are similar to
those published by Coleman et al. (1988a,b) in P. yoelii and
L. amazonensis coinfection experiments.
Rodent Malaria parasites provide great models to investigate
pathogenesis and immune mechanisms during infection (Li
et al., 2001; Zuzarte-Luis et al., 2014). The non-lethal strain
17XNL of P. yoelii generally causes a transient disease with
moderate parasitaemia, weight loss, splenomegaly, hypothermia,
and anemia (Coleman et al., 1988b; Kobayashi et al., 1996;
Niikura et al., 2008; Kolbaum et al., 2012; Karadjian et al., 2014).
In our study, BALB/c mice infected with blood-stage P. yoelii
17XNL develop a self-limiting infection with mild parasitaemia
that resolve in 4 weeks. Prior infection with L. braziliensis
reduced parasitaemia, while animals previously infected with
L. amazonensis showed a tendency to have higher parasitaemia
than Py single infected group. Mortality during acute Malaria
increased with L. amazonensis co-infection, demonstrating that
the existence of intrinsic differences between this two Leishmania
species during co-infection, may affect animal survival.
The course of experimental CL is dependent on a combination
of factors: Leishmania and host species, parasite strain, site, and
size of the inoculum among other aspects (Pereira and Alves,
2008; Pereira et al., 2009; Ribeiro-Gomes et al., 2014). The murine
model of subcutaneous infection with L. major generated a great
amount of data concerning the immune response in CL. It was
in this model that could be demonstrated the importance of a
type 1 (proinflammatory) specific immune response for healing
the infection in genetically resistant strains of mice (such as
C57BL/6), as well as the dominance of a type 2 immune response
(with a strong production of IL-4 and IL-10) in susceptible
BALC/c mice. On the other hand, all strains of mice that have
been tested so far using the subcutaneous route of infection
are susceptible to L. amazonensis, and non-permissive hosts for
L. braziliensis.
The intradermal rout of infection with low doses of parasites
in the ears, first developed for L. major infection (Belkaid et al.,
2000), proven also to be an important experimental model for
L. braziliensis studies. After intradermal infection in the ears with
L. braziliensis promastigotes BALB/c are able to develop ulcerated
lesions that heal spontaneously, similar to the most common
clinical manifestation of American Tegumentary Leishmaniasis
caused by L. braziliensis: the localized cutaneous form (de Moura
et al., 2005; Falcão et al., 2012; Carregaro et al., 2013). In the
present work, mice infected intradermally with L. braziliensis
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FIGURE 7 | Alterations in thymic T-cell subsets after infection with P. yoelii (Py), L. braziliensis (Lb), L. amazonensis (La), or co-infection with
Leishmania sp. and P. yoelii. The phenotype of T subsets in the thymus were determined by flow cytometry at days 5, 10, 17, and 25 post P. yoelii
infection. The percentages of CD4+, CD8+, CD4−CD8− double negatives (DN), and CD4+CD8+ double positive cells (DP) obtained in uninfected controls (open
bars) were compared to those obtained in Py single-infected mice (black bars) and in animals co-infected (checkered bars) or single infected (gray bars) with
L. braziliensis. (A) or L. amazonensis promastigotes (B). Results are expressed by the mean ± SEM of 4–6 mice per group. The Mann–Whitney test was used to
compare groups. (∗) statistically different from control, (#) statistically different from Leishmania sp. and (§) statistically different from Leishmania sp./P. yoelii
co-infected group.
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FIGURE 8 | Alterations in spleen T-cell subsets after infection with P. yoelii (Py), L. braziliensis (Lb), L. amazonensis (La), or co-infection with
Leishmania sp. and P. yoelii. The phenotype of T subsets in the spleen were determined by flow cytometry at days 5, 10, 17, and 25 post P. yoelii
infection. The percentages of CD4+, CD8+, CD4−CD8− double negatives (DN), and CD4+CD8+ double positive cells (DP) obtained in uninfected controls (open
circles) were compared to those obtained in Py single-infected mice (black triangles) and in animals co-infected (black diamonds with dashed line) or single infected
(black squares) with L. braziliensis. (A) or L. amazonensis promastigotes (B). Results are expressed by the mean ± SEM of 4–6 mice per group. The Mann–Whitney
test was used to compare groups. (∗) statistically different from control, (#) statistically different from Leishmania sp. and (§) statistically different from Leishmania
sp./P. yoelii co-infected group.
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developed a localized lesion that increased in size, became
ulcerated and self-resolved by week 16 post infection, as expected
(data not shown). Co-infected mice exhibited similar pattern
in lesions development, but those were smaller and presented
less ulcerations. L. amazonensis infection, on the other hand
induced progressive non-healing lesions, and at the end of the
study (11 weeks after L. amazonensis infection) 100% of the
animals presented ulcerated lesions. Interestingly, during acute
Py infection (in the 1st 4 weeks post L. amazonensis infection), co-
infected group presented a transitory delay on the development
of lesions as well as smaller lesions when compared to La
single-infected mice. As mentioned before, the differences in
susceptibility to Leishmania species in murine models, as well as
in humans, have multifactorial causes, one of them being the type
of immune response generated after infection. For this reason,
the differences observed in the disease outcome of L. braziliensis
and L. amazonensis infection during Malaria co-infection must be
evaluated in the context of the intense systemic immune response
elicited by P. yoelii 17XNL in the 1st weeks of Leishmania
infection.
It is well described that Malaria erythrocytic stage triggers a
strong IFN-γ response in both rodent and human Malaria (Shear
et al., 1989; Chen et al., 2010; Perez-Mazliah and Langhorne,
2014). The first wave of proinflammatory cytokines is sustained
by the innate immune system, when parasitaemia is still low,
and is characterized by the release of IFN-γ, TNF-α, IL-2, and
IL-12. The inflammatory environment sustains CD4+ T cell
polarization to a Th1 phenotype that provides more IFN-γ for
macrophages activation and control of parasitaemia (Artavanis-
Tsakonas and Riley, 2002; Artavanis-Tsakonas et al., 2003). In
our experiments, we were able to detect an early and pronounced
increase of IFN-γ levels in the serum of P. yoelii 17XNL single
infected and co-infected groups, mainly in the beginning of
the infection, as extensively described in literature (Shear et al.,
1989; Kobayashi et al., 1996; Shan et al., 2012; Karadjian et al.,
2014). While the enhanced levels of IFN-γ in the serum was
only transitory (5 and 10 days after P. yoelii 17XNL) the
levels of TNF and IL-6 also increased in animals infected with
P. yoelii 17XNL, but remained elevated for a longer period of
time (during patent parasitaemia) in the serum. Co-infected
groups presented smaller lesions than Leishmania single infected
groups and this effect occurred simultaneously with the increased
cytokines levels in the serum, during Malaria erythrocytic phase.
The strong proinflammatory environment caused by P. yoelii
17XNL infection could explain the delay on lesions development
in co-infected groups, given the fact that IFN-γ and TNF play
an essential role in controlling Leishmania replication inside
macrophages (Ashok and Acha-Orbea, 2014). Obviously a clearly
scenario can be achieve if we evaluate the Leishmania-specific
immune response developed in Leishmania single infected and
Leishmania /P. yoelii 17XNL co-infected groups. This matter is
currently under investigation.
In CL as well as in Malaria, excessive inflammatory response
can lead to pathology or even death. Therefore, the balance
between pro and anti-inflammatory cytokines is important to
control pathology and parasitaemia (Artavanis-Tsakonas et al.,
2003; Antonelli et al., 2005; Oliveira et al., 2014). Overall we could
observe a tendency for reduced levels of IFN-γ, TNF, IL-6, and IL-
10 in the serum of co-infected groups, when compared to P. yoelii
17XNL single infected group, suggesting a modulation of P. yoelii
17XNL induced immune response by Leishmania co-infection.
On the other hand, L. braziliensis and L. amazonensis co-infection
exerts opposite effects on P. yoelii 17XNL infection (Figures 2
and 3). IL-10 is a key regulatory cytokine to protect mice against
pathology during acute Malaria (Kobayashi et al., 1996; Freitas
do Rosario and Langhorne, 2012). Interestingly the reduction
in the serum levels of IL-10 reached statistically significance
only in L. amazonensis co-infected group at days 5 and 10 post
P. yoelii 17XNL infection. This significant reduction in serum IL-
10 levels could be linked to the persistent parasitaemia and deaths
observed in L. amazonensis co-infected group (Figure 2).
Similar to several other parasitic diseases, experimental
Malaria infections can cause severe thymic alterations (Savino,
2006; De Meis et al., 2012). During infection the organ undergoes
a strong atrophy with disruption of its architecture that may
influence T cell maturation. It has been already demonstrated
that mice infected with P. chabaudi or P. berghei, two other
rodent Malaria species, exhibit an important thymic atrophy with
cellular depletion and histological disorganization (Seixas and
Ostler, 2005; Andrade et al., 2008; Francelin et al., 2011; Lima
et al., 2012). Thymic atrophy caused by infectious diseases may
occur in combination with one or more of the following events:
impairment of thymocyte proliferation, increase in thymocyte
death and increase in thymocyte migration to peripheral
lymphoid tissue (De Meis et al., 2012). Increase in apoptosis and
thymocyte migration has been described in a variety of diseases
(Savino, 2006), including Malaria (Francelin et al., 2011).
Accordingly, in P. yoelii 17XNL infection we observed a
profound thymic atrophy with a reduction in the percentage
of double positive cells (CD4+CD8+) and an increase in the
percentage of single positive (CD4+ and CD8+) and double
negative cells (CD4−CD8−). We also observed a high degree
of apoptosis and necrosis in the thymocytes of P. yoelii single
infected and co-infected groups, with no difference between
groups (data not shown). Besides the intense atrophy during
acute Malaria, thymus was capable to recover its normal size
and cellularity after P. yoelii elimination, in accordance with
observations with P. chaubaudi non-lethal infection (Seixas
and Ostler, 2005). Infections with both Leishmania species
were not able to cause thymus involution in mice, probably
due to the localized nature of the cutaneous lesions they
cause, with no or little impact in the systemic immune
environment. Remarkably, thymus recovery occurred faster
in co-infected animals, what we believe is a reflection of
the minor inflammatory environment observed in co-infected
animals.
The reduction in double positive thymocytes has also been
described as common feature in infectious diseases, and can be
explained by a premature escape of immature cells to blood
and peripheral lymphoid organs (De Meis et al., 2012). P. yoelii
17XNL single infected and co-infected groups showed decreased
percentages of double positive CD4+CD8+ splenocytes when
compared to Leishmania single infected animals and uninfected
controls, suggesting that the reduced percentages of double
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positive cells in the thymus of those groups were not due to
increased migration to the peripheral lymphoid organs.
Among the mechanisms described to clear blood-stage
Malaria parasites are mature isotypes antibodies and antibody-
independent T cell mechanisms (Marsh and Kinyanjui, 2006;
Beeson et al., 2008), but all of them require the activation
of CD4+ T cells. In our model, CD4+ T cells presented a
transitory increase at 10dpi but presented a significant drop on
their percentages after 17 dpi when compared to controls. In
L. amazonensis co-infected group they equalized controls only at
25 dpi, while in L. braziliensis co-infection they were lower them
controls and Leishmania single infected group. The nature of this
cells (e.g., if they are regulatory the cells or effector T cells), as well
as the cytokines they produce after stimulation with Leishmania
antigens or P. yoelii infected erythrocytes are under investigation.
Interestingly the percentages of double negatives CD4
and CD8 splenocytes increased in P. yoelii 17XNL infected
groups, and Leishmania co-infection were able to delay this
enhancement. We are also performing multiparametric flow
cytometry experiments to better understand the phenotype of this
CD3+CD4−CD8−cells, since they can be NKT cells or γδT cells.
Both cell types are components of the innate immune system and
have been proposed to play significant roles in the clearance of
blood-stage malarial parasites (Stevenson and Riley, 2004; Urban
et al., 2005).
NKT cells are innate-like lymphocytes that account for
approximately 5% of T lymphocytes in the spleen. They posses
both T cell and NK cells surface markers since they can express
CD4 or CD8 co receptors on their surface, or neither one of
them (double-negative phenotype) as well as the NK1.1 surface
molecule (Balato et al., 2009). Primary P. yoelii infection with
non-lethal strain 265BY is able to induce an organ-specific
and heterogeneous NKT cells response (Soulard et al., 2007).
Hepatic NKT cells consisted mainly of CD1d-dependent CD4+
and double negative NKT cells, whereas splenic NKT cells
presented a CD1d-independent TCRhigh CD4high phenotype
during infection (Soulard et al., 2007). It was also demonstrated
that CD49b+ CD3+ natural killer T (NKT) cells increased in
the liver after a primary infection with P. yoelii non-lethal strain
(17XNL), and that CD1d-restricted NKT cells, which secrete
IFNγ, are critical to reduce liver-stage burden in a secondary
infection (Miller et al., 2014). Lack of type 1 IFN-alpha receptor
signaling compromise the enhancement of NKT cells in the liver,
showing a link between type I IFN signaling, cell recruitment, and
subsequent parasite elimination.
Gamma delta T cells are the first to be generated in
the ontogeny. They are able to respond quickly through the
production of cytokines and can be divided into two types:
interferon-producing cells (CD27hi) and IL-17-producing cells
(CD27lo) (Zarin et al., 2015). In Malaria they are activated during
pre-erythrocytic (liver) and erythrocyte stages and can produce
INF-γ in vitro after stimulation with P. falciparum infected
erythrocytes (Elloso et al., 1994; Farouk et al., 2004; Scholzen
and Sauerwein, 2016). In BALB/c mice, the number of γδT cells
increases considerably in the spleen during infection with P. yoelii
non-lethal strain (17XNL) (Kopacz and Kumar, 1999), while this
increase did not occur to the same extent in mice infected with
the lethal strain of P. yoelii (17XL) suggesting that γδT cells play a
protective role in Malaria (Kopacz and Kumar, 1999). In another
work with P. yoelii non-lethal strain was observed an increase
in the percentage of γδT cells in the spleen, liver and peripheral
blood, peaking at day 21 of infection (Li et al., 2012). When the
mice were depleted from γδT cells with monoclonal antibodies
parasite elimination was delayed (Li et al., 2012).
Our results demonstrating an increase in CD3+CD4−CD8−
cells during erythrocyte stage in P. yoelii 17XNL non-lethal strain
infected animals both in the thymus (Figure 7) and in the spleen
(Figure 8) does not discard the possibility that those can be either
NK T or γδT cells, and the delay of this enhancement to occur in
Leishmania co-infected groups when compared to P. yoelii single
infected animals could have a correlation with the differences in
cytokines production observed between P. yoelii 17XNL single
infected and co-infected groups.
Taken together, our results suggest that coexisting infection
with P. yoelii 17XNL and L. braziliensis or L. amazonensis
may change diseases outcomes, and that Malaria outcome can
be altered according to the Leishmania co-infection specie
evaluated. On the other hand Malaria infection produced
a transient delay on leishmanial lesions development. These
alterations on Malaria and CL progress seem to be closely related
to changes in the immune response as verified by alteration in
serum cytokine levels and thymus dynamics during infection.
In areas where Malaria and CL are co-endemic, human
populations are continuously exposed to Malaria and
Leishmaniasis vectors bites and consequently are at risk of
suffering repeated infections. These recurrent infections in
endemic areas might cause permanent immunomodulatory
effects, which can probably interfere in the outcome of both
diseases. Moreover, the increase in Malaria parasitaemia, patency
and mortality, observed in L. amazonensis/P. yoelii coinfection,
might contribute to the severity of disease as well as to the
maintenance of the malaria transmission in co-endemic areas.
Considering the importance and the geographical distribution
of Malaria and CL in tropical regions of the world, further
investigation on immunomodulatory mechanisms during co-
infection are necessary to understand how co-infection can affect
not only the natural history and progression of diseases but also
the treatment and prevention of both.
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